Amiodarone Dosing for Atrial Fibrillation
For rate control in AF, intravenous amiodarone should be administered as 150 mg over 10 minutes, followed by 1 mg/min for 6 hours, then 0.5 mg/min for 18 hours; oral amiodarone for rate control requires 600-800 mg daily in divided doses until 10 g total is given, then 200 mg daily maintenance. 1, 2, 3
Intravenous Amiodarone Dosing
Acute Rate Control Setting
Loading Phase:
- 150 mg IV bolus over 10 minutes (may repeat in 10-30 minutes if needed for breakthrough episodes)
- Follow with 1 mg/min continuous infusion for 6 hours
- Then 0.5 mg/min for 18 hours
- Total first 24-hour dose approximately 1000 mg 1, 3
Critical Administration Details:
- Must use volumetric infusion pump (NOT drop counters, which can underdose by 30%) 3
- Concentrations >2 mg/mL require central venous catheter 1, 3
- Initial infusion rate should not exceed 30 mg/min 3
- Maintenance infusion up to 0.5 mg/min can continue for 2-3 weeks 3
Clinical Context for IV Use
Class IIa indication (reasonable): IV amiodarone is useful for rate control when other measures (beta blockers, calcium channel blockers, digoxin) are unsuccessful or contraindicated 4, 5
Class I indication (recommended): In patients with AF and heart failure without accessory pathway, IV digoxin or amiodarone is recommended for acute rate control 6, 7
Important contraindication: IV amiodarone is potentially harmful (Class III: Harm) in patients with Wolff-Parkinson-White syndrome and pre-excited AF, as it may paradoxically accelerate ventricular response 6, 7. However, recent systematic review data suggests actual VF risk may be rare (0.12-0.68%) 8.
Oral Amiodarone Dosing
For Rate Control (Class IIb - May Be Considered)
Loading regimen:
- 600-800 mg daily in divided doses until total of 10 g administered 2
- Alternative loading: 800 mg daily for 1 week, then 600 mg daily for 1 week, then 400 mg daily for 4-6 weeks 9
Maintenance:
Oral amiodarone may be considered when resting and exercise heart rate cannot be adequately controlled with beta blockers, calcium channel blockers, or digoxin (alone or in combination) 4, 5
For Rhythm Control (Cardioversion/Maintenance of Sinus Rhythm)
Loading for ventricular arrhythmias:
- 800-1600 mg daily in divided doses until 10 g total given
- Then 200-400 mg daily maintenance 2
For AF cardioversion (Class I recommendation in specific contexts):
- IV amiodarone is recommended when cardioversion is desired in patients with severe LVH, heart failure with reduced ejection fraction, or coronary artery disease (where other agents are contraindicated) 11
- Onset of effect: 1-3 weeks for oral, <30 minutes for IV 1, 2
Transitioning from IV to Oral
When converting from IV to oral dosing 2:
- <1 week IV therapy: Start 800-1600 mg oral daily
- 1-3 weeks IV therapy: Start 600-800 mg oral daily
- >3 weeks IV therapy: Start 400 mg oral daily
Key Clinical Considerations
Monitoring requirements:
- Continuous ECG monitoring during IV administration 2
- Watch for hypotension (especially with IV), bradycardia, AV block 1, 2
- Long-term: pulmonary toxicity, thyroid dysfunction, hepatotoxicity, corneal deposits 1, 2
Efficacy data:
- IV amiodarone converts 80-87% of recent-onset AF to sinus rhythm 12, 13, 14
- Conversion time averages 12-20 hours depending on route 15
- Larger left atrial size and longer AF duration decrease effectiveness 13, 14
Common pitfall: The 2024 ACC/AHA/HRS guidelines 10 and 2024 ESC guidelines 11 emphasize that amiodarone should generally be reserved for patients with structural heart disease or when other agents fail, due to significant extracardiac toxicity with chronic use. Use the lowest effective dose and shortest duration possible.
Drug interactions: Amiodarone significantly increases digoxin levels (by 70% after one day), requiring 50% dose reduction of digoxin; increases warfarin effect requiring one-third to one-half dose reduction 3